Pharmacological inhibition of the interaction between APP and Lf while still maintaining the other reported neuroprotective roles of Lf could provide a potential therapeutic for AD, but more work is needed to understand what the interaction between holo-Lf and APP represents. This evidence concerns the gene LTF and Alzheimer disease.